Delivery Order SPE2DB20D3103-SPE2DB25FP4Z5
- Not listed
- AmerisourceBergen Drug Corp was awarded a Delivery Order valued at $3,061.45 by the Defense Logistics Agency (DLA) on July 14, 2025, for the supply of Mucus Relief DM ER 600-30 mg tablets (40-count). This is a firm fixed price, non-set-aside contract with a completion date of July 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Mucus Relief ER 600 mg tablets (500-count units) with a ceiling value of $1,572.44 and an ultimate completion date of September 15, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen, a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 500 tablets of Mucus Relief ER 600 mg, valued at $2,271.04, with an ultimate completion date of August 14, 2025. This firm fixed-price delivery order represents a non-competitive set-aside and will be fulfilled at the company's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor that supplies a comprehensive...
- The Defense Logistics Agency awarded a delivery order valued at $1,106.16 to AmerisourceBergen Drug Corp for 500 tablets of Mucus Relief ER 600 mg, with an ultimate completion date of August 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Mucus Relief DM ER 600-30 mg tablets (40-count package) with a ceiling value of $2,917.37. This is a firm fixed-price delivery order with a completion date of October 20, 2025, issued with no set-aside designation under competitive procurement procedures. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Mucus Relief DM ER 600-30 mg tablets (20-count packages) with a ceiling value of $1,025.79. This firm fixed-price delivery order, which is scheduled for completion by April 25, 2025, represents a non-competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place of performance is located in...
- The Defense Logistics Agency awarded a delivery order valued at $1,896.87 to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Mucinex ER 600 mg tablets (40-count packages). This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract calls for ultimate completion by September 18, 2025, and the place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a...
- This is a $3,327.51 firm fixed price delivery order (SPE2DB24FJRK7) awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp. The contract is for the supply of 4565461978 MUCUS RELIEF ER 600 MG TABLET 100S. The contract has an ultimate completion date of August 16, 2024. This appears to be a continuation of Amerisourcebergen's broader supply relationship with DLA, as the company holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical for...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $3,746.61, is for the delivery of "MUCUS RELIEF ER 600 MG TABLET 500S" and has a completion date of March 6, 2025. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,706.85 on July 28, 2025, for the supply of Mucinex DM ER 600-30 mg tablets in quantities of 20 units. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 29, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP4Z5Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,610.76 for 500 tablets of Mucus Relief ER 600 mg, with an ultimate completion date of July 15, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreement with DLA. This award reflects AmerisourceBergen's role as a critical pharmaceutical distributor within the federal medical supply chain, particularly supporting military and veteran healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, which serves as the vehicle enabling this and similar delivery orders for pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen's extensive portfolio of federal contracts demonstrates its capability to fulfill diverse medical procurement requirements across multiple therapeutic domains on a competitive basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 7/14/25 |